Compound Detail
CHEMBL2095212
MIRABEGRON 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL2095212 |
| Name | MIRABEGRON |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PBAPPPCECJKMCM-IBGZPJMESA-N |
| Therapeutic | ✓ Yes |
1
Targets
1
Activities
1
Assay Types
12
PK Parameters
20
Publications
7
Known Names
16
Indications
1
Mechanisms
Molecular Properties
396.5
MW (Da)
2.77
ALogP
6
HBA
4
HBD
100.3
PSA (Ų)
0.42
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2012 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Beta-3 adrenergic receptor agonist | AGONIST | Beta-3 adrenergic receptor | ✓ | ✓ |
Indications
Polyuria Urinary Bladder, Overactive Urinary Incontinence Urinary Incontinence, Urge Cystitis, Interstitial Kidney Calculi Cerebral Hemorrhage Heart Failure Hypertrophy, Left Ventricular Pain Prediabetic State Urinary Bladder, Neurogenic Kidney Diseases Liver Diseases Polycystic Ovary Syndrome Esophageal Achalasia
ATC Classification
G04BD12
mirabegron
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
Activity Summary
EC50 1 meas. best 7.65
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-3 adrenergic receptor CHEMBL246 | EC50 | 7.65 | 7.65 | 22.4 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2285.0 | ng.hr.mL-1 | Homo sapiens |
| CLr | 17.7 | L/hr | Homo sapiens |
| Cmax | 935.64 | nM | Homo sapiens |
| F | 23.0 | % | Rattus norvegicus |
| F | 48.4 | % | Rattus norvegicus |
| F | 75.7 | % | Rattus norvegicus |
| F | 41.8 | % | Canis lupus familiaris |
| F | 64.6 | % | Canis lupus familiaris |
| F | 77.1 | % | Canis lupus familiaris |
| T1/2 | 47.9 | hr | Homo sapiens |
| T1/2 | 72.9 | hr | Homo sapiens |
| Tmax | 1.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Beta-3 adrenergic receptor | EC50 | = | 22.4 | nM | 7.65 | Agonist activity at human beta-3 adrenoceptor expressed in CHO cells assessed as... | 36758304 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5724801 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5058577 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058577 | U2OS | 304 |
| - | 10.6019/CHEMBL5058577 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5724801 | U2OS | 304 |
| - | 10.6019/CHEMBL5724801 | HEK-293T | 304 |
| 22269146 | 10.1124/dmd.111.043588 | Plasma | 11 |
| 26125514 | 10.1021/acs.jmedchem.5b00638 | Rattus norvegicus | 10 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 6 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 5 |
| 28355078 | 10.1021/acs.jmedchem.6b01197 | Rattus norvegicus | 4 |
| 26709102 | 10.1021/acs.jmedchem.5b01372 | Rattus norvegicus | 4 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 3 |
| 22269146 | 10.1124/dmd.111.043588 | Canis familiaris | 3 |
| 22269146 | 10.1124/dmd.111.043588 | Rattus norvegicus | 3 |
| - | 10.6019/CHEMBL5058564 | U2OS | 3 |
| 22269146 | 10.1124/dmd.111.043588 | ADMET | 3 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 2 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
Data from ChEMBL 36 via Core Engine